Idorsia Pharmaceuticals Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Allschwil Switzerland (2017)

Organization Overview

First Clinical Trial
2017
NCT03245229
First Marketed Drug
2022
act-541468
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Idorsia Pharmaceuticals | Idorsia Pharmaceuticals Ltd. | IDORSIA PHARMACEUTICALS LTD.